Our Company

Our Company

Our Story

Leading the Way on Rare and Serious Diseases

The CSL Behring Commitment

The CSL Behring Commitment

Environment

Giving Back

Workplace Health and Safety

Global Leadership Group

Worldwide Locations

Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
Learn More

It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
Learn More
Patients

Patients

Find Your Disease

Find Your Disease

Immunodeficiency and Autoimmune Diseases

Hereditary Bleeding Disorders

Hereditary Angioedema

Alpha 1 Antitrypsin Deficiency

Community Engagement

Community Engagement

Patient Programs in USA

LEAD Grants USA

Support and Assistance

We work with government authorities to ensure patients have access to care while also funding medical research.
Learn More

We also aim to make sure that nothing holds you back from getting the therapies you need.
Learn More
R&D

R&D

R&D Capabilities

Product Pipeline

Clinical Studies at CSL Behring

Clinical Studies at CSL Behring

Current Clinical Trials

Research Practices

What is a Clinical Trial

Awards and Grants

Awards and Grants

Professor Heimburger Award

Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
Learn More

A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Learn More
Products

Products

Global Products List

Safety and Manufacturing

Regulatory Compliance

Patents

Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
Learn More

CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Learn More
Careers

Careers

See Yourself at CSL Behring

Diversity & Inclusion

How We Care for You at CSL

Discover Our People

Help us deliver on our promise to save lives and protect the health of people.
Learn More

Make your well-being a priority. It's important and so are you.
Learn More
Vita Stories

Our Company
- The CSL Behring Commitment
Patients
- Find Your Disease
- Community Engagement
R&D
- Clinical Studies at CSL Behring
- Awards and Grants
Products
Careers

Messages of Hope: Mary Ann Massolio

Von Willebrand Disease didn’t stop Mary Ann from finishing 15 marathons.

By Patrick Mairs 29 Mar 2019

Message of Hope from rare disease patient Mary Ann who is living with von willebrand disease

Get the latest stories from Vita by signing up for our newsletter.

Popular search terms:

Corporate

CSL Limited (Global)

CSL Behring Worldwide

Americas

Asia Pacific

Europe